ARWR·04280A100·US·equity·Healthcare - Biotechnology-Activist
ARWR (ARROWHEAD PHARMACEUTICALS IN) is held by 194 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), Avoro Capital Advisors LLC ($670.9M), FMR LLC ($455.6M). Net institutional sentiment: Mixed.
See how ARWR's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer